Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

38.36
-0.5386-1.38%
Post-market: 38.360.00000.00%16:10 EDT
Volume:7K
Turnover:284.20K
Market Cap:4.80M
PE:- -
High:39.06
Open:39.06
Low:38.36
Close:38.90
52wk High:45.88
52wk Low:25.71
Shares:125.00K
Float Shares:125.00K
Volume Ratio:0.49
T/O Rate:5.82%
Dividend:0.62
Dividend Rate:1.62%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Amgen is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Sep 05

Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000

Reuters
·
Sep 04

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 04

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst

TIPRANKS
·
Sep 04

Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project

TIPRANKS
·
Sep 04

Argenx Se (ARGX) Gets a Buy from Jefferies

TIPRANKS
·
Sep 03

Argenx Price Target Maintained with a $1150.00/Share by Wedbush

Dow Jones
·
Sep 03

Political and General News Events from September 3

Reuters
·
Sep 03

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Reuters
·
Sep 03

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 03

Argenx Se : Jefferies Raises Target Price to $1215 from $1140

THOMSON REUTERS
·
Sep 03

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

TIPRANKS
·
Sep 03

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Reuters
·
Sep 03

Amgen to Present at Wells Fargo Healthcare Conference Webcast

Reuters
·
Sep 03

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Reuters
·
Sep 03

Regeneron Announces Q3 2026 Dividend of R$ 0.05 Per Unit

Reuters
·
Sep 03

Political and General News Events from September 2

Reuters
·
Sep 02

uniQure seeks accelerated approval for Huntington’s gene therapy

TIPRANKS
·
Sep 02

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.
·
Sep 02

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

TIPRANKS
·
Sep 02